In this week’s episode of DeviceTalks Weekly we review the Medical Design & Outsourcing’s Women in Medtech issue — bringing you insights through interviews with Katie Syzman, corporate VP and the GM of critical care at Edwards Lifesciences, Naomi Murray, Stryker’s director of advanced operations, and Patty Post, CEO of Startup Checkable Medical.
Szyman will share Edwards’ view of artificial intelligence.
In our closing keynote conversation, Vijay Kumar, managing director at Evercore ISI, will explain why Exact Science’s acquisition of liquid biopsy company wasn’t exactly a surprise (though the $2 billion price tag might have been.) He also assesses Boston Scientific’s COVID-19 comeback. What does the rise in cases mean for the company and the rest of medtech?
Chris Newmarker, executive editor of life sciences, delivers this week’s Newmarker’s Newsmakers which highlights reports on Abbott, Baxter, Intuitive Surgical and Siemens. Editor Danielle Kirsh also is on hand to talk through the MassDevice Big 100 report. Assistant editor Sean Whooley also joins the conversation.